
Publications of Dieter E. Jenne
All genres
Journal Article (82)
2023
Journal Article
75 (5), pp. 748 - 759 (2023)
Activation of a latent epitope causing differential binding of anti-neutrophil cytoplasmic antibodies to proteinase 3. Arthritis and Rheumatology
Journal Article
299 (4), 103072 (2023)
Constitutive and induced forms of membrane-bound proteinase 3 interact with antineutrophil cytoplasmic antibodies and promote immune activation of neutrophils. The Journal of Biological Chemistry
Journal Article
20, 291 (2023)
An engineered Fc fusion protein that targets antigen-specific T cells and autoantibodies mitigates autoimmune disease. Journal of Neuroinflammation
Journal Article
15 (6), 1866 (2023)
Non-oncogene addiction of KRAS-mutant cancers to IL-1beta via versican and mononuclear IKKbeta. Cancers / Molecular Diversity Preservation International (MDPI) 2022
Journal Article
132 (23), e160089 (2022)
Protective alpha1-antitrypsin effects in autoimmune vasculitis are compromised by methionine oxidation. The Journal of Clinical Investigation
Journal Article
219 (10), e20220759 (2022)
Monocyte-derived macrophages aggravate pulmonary vasculitis via cGAS/STING/IFN-mediated nucleic acid sensing. The Journal of experimental medicine 2021
Journal Article
57 (5), 2001416 (2021)
Cathepsin B promotes collagen biosynthesis, which drives bronchiolitis obliterans syndrome. European Respiratory Journal
Journal Article
81 (13), pp. 3568 - 3579 (2021)
TIMP1 triggers neutrophil extracellular trap formation in pancreatic cancer. Cancer Research
Journal Article
57 (4), 2003755 (2021)
Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia. European Respiratory Journal 2020
Journal Article
63 (22), pp. 13258 - 13265 (2020)
Lung protection by cathepsin C inhibition: A new hope for COVID-19 and ARDS? Journal of Medicinal Chemistry 2019
Journal Article
10, 1189 (2019)
The glycosylation site of myelin oligodendrocyte glycoprotein affects autoantibody recognition in a large proportion of patients. Frontiers in immunology
Journal Article
164, pp. 349 - 367 (2019)
Structure-based design and in vivo anti-arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C. Biochemical Pharmacology
Journal Article
20 (19), 4747 (2019)
Processing and maturation of cathepsin C zymogen: A biochemical and molecular modeling analysis. International Journal of Molecular Sciences
Journal Article
9, 9925 (2019)
Premedication with a cathepsin C inhibitor alleviates early primary graft dysfunction in mouse recipients after lung transplantation. Scientific Reports 2018
Journal Article
37 (8), pp. 1021 - 1028 (2018)
Preservation with α1-antitrypsin improves primary graft function of murine lung transplants. The Journal of Heart and Lung Transplantation
Journal Article
61 (5), pp. 1858 - 1870 (2018)
Exploiting the S4-S5 specificity of human neutrophil proteinase 3 to improve the potency of deptidyl Di(chlorophenyl)-phosphonate ester inhibitors: A kinetic and molecular modeling analysis. Journal of Medicinal Chemistry
Journal Article
293 (32), pp. 12415 - 12428 (2018)
Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis. The Journal of Biological Chemistry
Journal Article
84 (2), pp. 315 - 328 (2018)
Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein. Annals of Neurology 2017
Journal Article
131, pp. 52 - 67 (2017)
Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases. Biochemical Pharmacology 2016
Journal Article
6, 35413 (2016)
Quantitative analysis of protease recognition by inhibitors in plasma using microscale thermophoresis. Scientific Reports
Journal Article
283 (3), pp. 498 - 509 (2016)
Analysis of urinary cathepsin C for diagnosing Papillon-Lefevre syndrome. The FEBS Journal
Journal Article
291 (16), pp. 8486 - 8499 (2016)
Neutrophilic cathepsin C is maturated by a multistep proteolytic process and secreted by activated cells during inflammatory lung diseases. The Journal of Biological Chemistry
Journal Article
68 (3), pp. 603 - 630 (2016)
Inhibitors and antibody fragments as potential anti-inflammatory therapeutics targeting neutrophil proteinase 3 in human disease. Pharmacological Reviews 2015
Journal Article
6, 6722 (2015)
Autoprocessing of neutrophil elastase near its active site reduces the efficiency of natural and synthetic elastase inhibitors. Nature Communications
Journal Article
59, pp. 43 - 52 (2015)
Allosteric modulation of proteinase 3 activity by anti-neutrophil cytoplasmic antibodies in granulomatosis with polyangiitis. Journal of Autoimmunity
Journal Article
6, 7333 (2015)
γ-secretase directly sheds the survival receptor BCMA from plasma cells. Nature Communications 2014
Journal Article
289 (46), pp. 31777 - 31791 (2014)
New selective peptidyl Di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases. The Journal of Biological Chemistry
Journal Article
184 (8), pp. 2197 - 2210 (2014)
Unopposed cathepsin G, neutrophil elastase, and proteinase 3 cause severe lung damage and emphysema. American Journal of Pathology
Journal Article
190 (11), pp. 1203 - 1204 (2014)
Off-target rewards of augmentation therapy with α1-antitrypsin. American Journal of Respiratory and Critical Care Medicine 2013
Journal Article
21 (6), p. 590 - 590 (2013)
Functional characterization of desmin mutant p.P419S Reply [Letter]. European journal of human genetics
Journal Article
288 (37), pp. 26635 - 26648 (2013)
A monoclonal antibody (MCPR3-7) interfering with the activity of proteinase 3 by an allosteric mechanism. The Journal of Biological Chemistry
Journal Article
191 (7), pp. 3594 - 3604 (2013)
Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases. Journal of Immunology
Journal Article
210 (13), pp. 2921 - 2937 (2013)
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. Journal of Experimental Medicine
Journal Article
8 (9), e75141 (2013)
Global substrate profiling of proteases in human neutrophil extracellular traps reveals consensus motif predominantly contributed by elastase. PLoS One
Journal Article
191 (5), pp. 2700 - 2707 (2013)
NSP4 is stored in azurophil granules and released by activated neutrophils as active endoprotease with restricted specificity. Journal of Immunology 2012
Journal Article
20 (9), pp. 984 - 985 (2012)
Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy 7 is caused by a DES mutation. European journal of human genetics
Journal Article
84 (8), pp. 3523 - 3530 (2012)
Direct detection of antibody concentration and affinity in human serum using microscale thermophoresis. Analytical Chemistry
Journal Article
42 (3), pp. 710 - 715 (2012)
The NLRP3/ASC/Caspase-1 axis regulates IL-1 ss processing in neutrophils. European Journal of Immunology
Journal Article
8 (6), pp. 501 - 503 (2012)
Perspectives and potential roles for the newly discovered NSP4 in the immune system. Expert Review of Clinical Immunology
Journal Article
109 (16), pp. 6229 - 6234 (2012)
NSP4, an elastase-related protease in human neutrophils with arginine specificity. Proceedings of the National Academy of Sciences of the United States of America 2011
Journal Article
186 (2), pp. 1131 - 1139 (2011)
Neutrophils require SHP1 to regulate IL-1β production and prevent inflammatory skin disease. Journal of Immunology
Journal Article
89 (1), pp. 23 - 28 (2011)
Tailor-made inflammation: How neutrophil serine proteases modulate the inflammatory response. Journal of Molecular Medicine
Journal Article
140 (4), pp. 1272 - 1282 (2011)
Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis. Gastroenterology
Journal Article
77 (6), pp. 580 - 588 (2011)
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 2010
Journal Article
62 (4), pp. 726 - 759 (2010)
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases. Pharmacological Reviews
Journal Article
185 (1), pp. 387 - 399 (2010)
Mapping of Conformational Epitopes on Human Proteinase 3, the Autoantigen of Wegener's Granulomatosis. Journal of Immunology
Journal Article
235, pp. 159 - 171 (2010)
Delivery and therapeutic potential of human granzyme B. Immunological Reviews
Journal Article
35 (4), pp. 299 - 308 (2010)
Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener's autoantigen. Journal of Autoimmunity 2009
Journal Article
15 (6), pp. 623 - 625 (2009)
Netting neutrophils in autoimmune small-vessel vasculitis. Nature Medicine
Journal Article
75A (7), pp. 626 - 633 (2009)
Gold Fluorescent Annexin A5 as a Novel Apoptosis Detection Tool. Cytometry Part A